Transgenic mice that express Cre recombinase under control of a skeletal muscle-specific promoter from mef2c.
Genes expressed in skeletal muscle are often required in other tissues. This is particularly the case for cardiac and smooth muscle, both contractile tissues that share numerous characteristics with skeletal muscle, such that targeted inactivation can lead to embryonic lethality prior to a requirement for gene function in skeletal muscle. Thus, it is essential that conditional inactivation approaches are developed to disrupt genes specifically in skeletal muscle. In this report, we describe a transgenic mouse that expresses Cre recombinase under the control of a skeletal muscle-specific promoter from the mef2c gene. Cre expression in this transgenic line is completely restricted to skeletal muscle from early in development and is present in all skeletal muscles, including those of epaxial and hypaxial origins and in fast and slow fibers. This early skeletal muscle-specific Cre line will be a useful tool to define the function of genes specifically in skeletal muscle.
Heidt
Analeah B
AB
Cardiovascular Research Institute, University of California, San Francisco, California 94143-0130, USA.
Black
Brian L
BL
D000818:Animals; D018929:Cell Culture Techniques; D019426:Integrases / Q000096:biosynthesis* / Q000235:genetics*; D064326:MEF2 Transcription Factors; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics*; D018482:Muscle, Skeletal / Q000502:physiology*; D018006:Myogenic Regulatory Factors / Q000502:physiology*; D011401:Promoter Regions, Genetic
D064326:MEF2 Transcription Factors; C578041:Mef2c protein, mouse; D018006:Myogenic Regulatory Factors; C045073:Cre recombinase; D019426:Integrases